Related Experiment Video
Updated: Apr 23, 2026
09:31
In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses
Published on: March 30, 2015
7.8K
Basic and clinical research in the AMC Renal Transplant Unit
Ineke J M ten Berge1, Fréderike J Bemelman1
1Renal Transplant Unit, Department of Internal Medicine, Academic Medical Centre, Amsterdam, The Netherlands.
Transplant Immunology
|September 22, 2014
Summary
This study characterizes T cell responses to cytomegalovirus (CMV) and BK virus (BKV) in kidney transplant recipients. It investigates how these antiviral immune responses affect alloimmunity and optimizes immunosuppression strategies.
Area of Science:
- Immunology
- Transplantation
- Virology
Background:
- Kidney transplant recipients face risks from latent viruses like cytomegalovirus (CMV) and BK virus (BKV).
- Understanding virus-specific T cell immunity is crucial for managing post-transplant complications.
- Alloimmunity and immunosuppression significantly impact transplant outcomes and patient health.
Purpose of the Study:
- To characterize antiviral T cell responses (differentiation, function, memory) to CMV and BKV in kidney transplant patients.
- To investigate the interplay between virus-specific immunity and alloimmune responses.
- To determine optimal immunosuppressive drug regimens and their effects on infections, cognition, and cardiovascular health.
Main Methods:
- Flow cytometry for T cell phenotyping and functional assays.
- ELISpot assays for quantifying virus-specific T cell responses.
- Analysis of clinical data on infectious diseases, cognitive function, and cardiovascular status.
Main Results:
- Detailed characterization of T cell dynamics against CMV and BKV post-transplantation.
- Insights into how antiviral immunity modulates the risk of alloimmune reactions.
- Data on the multifaceted impact of immunosuppression on transplant recipients' overall health.
Conclusions:
- Tailored immunosuppression strategies can improve outcomes for kidney transplant recipients.
- Understanding virus-specific immunity is key to preventing post-transplant complications.
- Further research is needed to optimize long-term management and quality of life.
